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Abstract 
This autumn influenza vaccine will again be offered to all two- and three-year-olds in 
general practice.  In addition, all children in clinical risk groups aged 6 months and 
above should be offered vaccine. Children in primary school years from reception 
class to year 4 will also be offered the vaccine as part of the on-going extension of 
influenza vaccination to healthy children. Since the start of the paediatric 
programme, transmission of influenza has reduced across all age groups in those 
parts of the country vaccinating all children of primary school age.  Children under 
five years of age have the highest rate of hospital admissions for influenza. However, 
many parents do not think that influenza is a serious illness and it is the vaccine they 
are most likely to decline.  Health care professionals are the most trusted source of 
advice and information about vaccination, so staff in general practice have a crucial 
role to play in recommending this vaccine to parents. 
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Key points 
 Influenza vaccine is offered to children to provide protection to the individual 
children as well as to reduce transmission across all ages. 
 Results from pilot areas in England have shown a positive population impact on 
influenza transmission from vaccinating children of primary school age both in the 
children themselves and in the wider population.  
 Influenza can cause serious illness in children. Children under five years of age 
have the highest rate of hospital admissions for influenza of all age groups. 
 Healthcare professionals are the most trusted source of information and advice 
on immunisation and discussions increase parental confidence, particularly 
among black and ethnic minority parents.  
 General practice staff have a key role to play in advocating the child influenza 
vaccine to parents. 
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Introduction 
Influenza immunisation, recommended in the UK since the 1960s, aims to protect 
those who are at higher risk of influenza associated morbidity and mortality.  
Originally targeted at those in clinical risk groups, the programme was extended in 
2000 to all people aged 65 years and over.  In 2010, after the 2009 pandemic, 
pregnancy was added due to evidence that pregnant women are at increased risk of 
complications from influenza.   
In 2012 the Joint Committee on Vaccination and Immunisation (JCVI), the 
independent expert group that advises Government on vaccination policy, 
recommended extending influenza immunisation to children.  The aim is to provide 
individual protection to the vaccinated children themselves and reduce transmission 
across all ages.  Influenza is an unpleasant but self-limiting illness in the majority of 
children, but it can cause serious complications and death, even in previously 
healthy children. Children under five years of age have the highest rate of hospital 
admissions for influenza (Cromer et al, 2014).   JCVI recommended that all eligible 
children are offered a live attenuated influenza vaccine (LAIV), administered as a 
nasal spray (JCVI, 2012). 
In 2013/14 the influenza immunisation programme began with pre-school children 
offered vaccination through GP surgeries.  For the first year the offer was to all two- 
and three-year-olds, the following year it was extended to four-year-olds. When the 
programme began geographically discrete pilots in England were also run for 
primary school aged children (and for one year only secondary school aged children 
aged 11-13 years), with the vaccine mostly delivered through schools but also in 
pharmacies and general practice in a few areas.   
In 2015/16 the programme was rolled out nationally to primary schools starting with 
children in years 1 and 2  (aged 5–6 years) and then for years 1, 2, and 3 (aged 5-7 
years) in 2016/17, with year 4 (8 year olds) being added this year (2017/18).  This 
coming year four year olds, previously offered the vaccine in general practice, will be 
offered it in reception class at school. General practices will be offering influenza 
vaccination to two- and three-year-olds in 2017/18 and will continue to offer 
vaccination to children in clinical risk groups.  This includes at risk children covered 
by the school vaccination programme if their parents prefer vaccination to be given in 
general practice. 
Influenza vaccine uptake rates for children    
JCVI recommended schools as the most effective route to deliver immunisations to 
school-aged children.  Table 1 gives vaccine uptake rates in general practice and 
those in school-aged children are given in table 2.  It shows that school aged 
children have higher uptake rates than younger children offered the vaccine in 
general practice, and that uptake in schools in the national roll-out is higher in the 
younger than older aged children.  
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Table 1: End-of-season Influenza vaccine uptake in 2 to 4 year olds in England 
from 2013/14 – 2016/17 (PHE, 2017a) 
Age 2013/14 2014/15 2015/16 2016/17 
2 years old 42.6% 38.5% 35.4% 38.9% 
3 years old 39.5% 41.3% 37.7% 41.5% 
4 year old N/A 32.9% 30% 33.9% 
 
Table 2: End-of-season Influenza vaccine uptake in national roll-out to school 
aged children in England from 2015/16 – 2016/17 (PHE, 2017b) 
Age 2015/16 2016/17 
Year 1 (Age 5-6) 54.4% 57.6% 
Year 2 (age 6-7) 52.9% 55.4% 
Year 3 (age 7-8) N/A 53.3% 
 
Vaccine uptake in children in clinical risk groups, who are offered the vaccine for 
their own individual protection, is given in figure 1.  Historically uptake is lower in at 
risk children compared to at risk adults, and is particularly low for the 6 months to 
under 2 years age group.  This is despite parents of children in clinical risk groups 
responding well to interventions encouraging vaccination, because it appeals to 
parental instincts to nurture and protect their children’s health (NICE, 2017).  
Figure 1: Vaccine uptake in the under 65 at risk groups by age (PHE, 2017a) 
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Public Health England (PHE) has produced good practice guidance for general 
practice outlining key strategies to improve uptake in children. The evidence is that 
strategies such as identifying a member of staff with responsibility for running the 
influenza vaccination campaign and sending personal invitations (call-recall) to 
parents increases uptake (PHE 2017c).   
The impact of the children’s programme on influenza levels 
Since the introduction of the LAIV programme for children the vaccine effectiveness 
for laboratory confirmed infection has been good.  In 2015/16 the 58% vaccine 
efficacy found in the UK was within the normal range for this vaccine (Pebody et al., 
2016). JCVI has recommended that the UK continues with the programme (JCVI, 
2016).    
 
Evaluation of the first two years of the programme compared pilot areas, where the 
entire primary school age cohort was offered vaccination, to non-pilot areas in 
England where no primary school vaccination was given.  The results show a 
positive impact on influenza transmission across a range of surveillance indicators 
including reductions in:  
 GP consultations for influenza-like illness  
 Influenza swab positivity in primary care  
 laboratory confirmed hospitalisations  
 respiratory emergency department attendances.   
 
These effects were evident in both targeted and non-targeted age groups compared 
with populations where primary-school age children were not vaccinated (Figure 2). 
The size of the effect was less for more severe outcomes, in particular excess 
mortality (Pebody et al, 2014; Pebody et al, 2015).   
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Figure 2: Flu vaccine pilot success in 2014/15. 
 
 
What parents think about influenza vaccination  
Although influenza vaccination rates in England are some of the highest in Europe, 
there are a number of misconceptions about influenza and the vaccine.  
PHE commissions an annual survey of nearly 2,000 parents of children under the 
age of five on their views about all vaccines offered to their children.  The survey 
consistently shows very high levels of confidence in the vaccine programme, with 
parents automatically having their children vaccinated when vaccines are due 
(Campbell et al, 2017). The survey includes specific questions about the influenza 
vaccine.   
The 2017 survey shows that awareness amongst parents of children eligible for the 
influenza vaccine is high at 84%. While uptake rates across the routine childhood 
vaccination programme are high with almost all vaccines exceeding 90% uptake, the 
vaccine that parents are most likely to refuse for their children is the influenza 
vaccine.   
Research at the start of the paediatric programme suggests that parents who 
typically support vaccination may doubt the necessity of an influenza vaccination for 
their child (Moulsdale et al., 2017).  Uptake is lower amongst children living in areas 
of higher deprivation (Green et al., 2015) and in larger families (Hardelid et al., 2016) 
and amongst ethnic minority groups (Green et al., 2015), with these effects still 
evident in the programme (PHE, 2017d). 
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Parents do not perceive the influenza vaccine to be as important as other childhood 
vaccines.  In the PHE annual survey parents are asked about their perceptions of the 
severity of a number of vaccine preventable diseases.  In 2010, when influenza 
vaccination was only offered to at risk children, just 8% of parents perceived 
influenza to be ‘very serious’. Since then this has increased year on year from 22% 
in 2015 to 27% in 2017. 
The offer of influenza vaccination to young children appears to have increased the 
understanding of parents that influenza can be very serious.  However, it is still 
considered to be less serious relative to other vaccine preventable illness. For 
example, compared to the diseases ranked as most serious in a scale of severity, 
meningitis, septicaemia and pneumonia, which 85%, 82%, 76% of parents 
respectively said were ‘very serious’, influenza was ranked much lower at 24%, 
despite pneumonia being a relatively common complication of influenza.   
The role of the healthcare professional in recommending influenza vaccination 
In the PHE survey parents are asked where they get information and advice about 
immunisation from.  Over the years the survey has consistently shown how important 
discussions with health professionals are.  In 2017, 74% of parents said they had 
such a discussion before their child was immunised.  Of these parents, 58% felt 
more confident about immunising their child; among black and ethnic minority 
parents, this figure rose to 72%.   
Healthcare professionals are seen as the most trusted source of advice on 
immunisation with 93% of parents agreeing that they trust their advice, compared to 
60% when this advice comes from family and friends, and only 30% when the 
information is from the media.  In a study in six European countries, general 
practitioners were listed as being the most trustworthy source of health information 
about medicines (Bouder et al., 2015). 
Primary care health professionals have a key role in advocating for the influenza 
vaccine but many parents are not receiving an invitation to attend for the vaccine 
from their GP surgery.  One study indicated that almost half of participants disagreed 
that a health professional had recommended vaccination (Smith et al, 2017).  Draft 
guidelines from NICE on improving influenza vaccine uptake recommend that 
practices should have a systematic way of identifying eligible patients and inviting 
them for vaccination, as well as identifying opportunities when parents have contact 
with the general practice for other reasons.   The draft NICE guidelines recognise the 
trusted role of healthcare professionals in providing advice on influenza vaccination.  
They emphasise the importance of those coming into contact with eligible groups 
being able to provide tailored information on the risks and benefits of influenza.  
They should also be able to offer and administer it (NICE, 2017).  To help support 
this PHE makes available resources aimed at parents, which explain why children 
are being offered the vaccine, which can be ordered free of charge (PHE 2017e).    
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Conclusion 
Children under five years of age have the highest rate of hospital admissions for 
influenza of all age groups.  Despite this, influenza is not seen as a serious illness in 
children by most parents and is the vaccine that they are least likely to accept for 
their child if offered.  Health professionals are the most trusted source of information 
and advice for parents on vaccination, and parental confidence in immunisation is 
improved by having a discussion with a health professional, especially for parents 
from black and ethnic minority groups.  Staff providing the influenza vaccine in 
general practice have a key role to play in recommending the vaccine for children 
and ensuring all eligible groups are actively invited for vaccination each season.  The 
impact of the vaccination programme extends beyond the individual children 
protected by the vaccine.  By reducing transmission of influenza from children further 
protection is extended to the wider population, including those who may be 
particularly vulnerable to influenza complications and may not respond well to their 
own influenza immunisation.   
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